Back to search

National and Kapodistrian University of Athens

Μελέτη συµπλόκων των στοιχείων χαλκού, µολυβδαινίου και κοβαλτίου µε χηλικούς υποκαταστάτες. Εφαρµογή στη θεραπεία και τη διάγνωση

Abstract

dc:description

The subject of the doctoral thesis concerns the study of some transition metal complexes with chelating agents that are of biological and pharmacological interest. Particularly, the reaction of copper, molybdenum and cobalt with the ligands DiHydroxyBenzoic Acids (3,4-, 2,3- and 2,5-DHBA), L-Carnitine, Ascorbic Acid (AscA) and 2,3-DiHydroxy-Pyridine (2,3-DHP) is investigated. The common chemical feature of these molecules is that they can act as multidentate ligands forming also bidentate complexes with O-/O- or N-/Odonor atoms, which can be used as models for several biological cycles (enzymatic etc.). These ligands are important metabolites of organisms and frequently are used for therapeutic applications. The mentioned transition metals are essential nutrients for humans and plants participating in many biological functions such as oxygen activation. Molybdenum forms monomeric, oligomeric or polymeric complexes, depending on the synthetic experimental conditions. Recently, a lot of interest is concentrated on the polyoxo-molybdenum complexes, because of their possible applications in catalysis, new materials and pharmaceuticals (they are tested as antitumor, antidiabetic and antivirus drugs). Studying the reaction of Mo(VI) with catecholic derivatives, in weakly acidic aqueous solutions, a dimeric complex with 2,3-DHBA was prepared and characterized with spectroscopic methods, having the formula (PPh4)2[Mo2O5(2,3-DHBA)2(ΟΗ)2]. The presence of O2 leads to complexes with the ligand in the semiquinonate type, while the Μο2Ο5 2+ moiety makes a bridge between the two semiquinone molecules, allowing an electronic charge interaction. At higher pH, a monomeric complex was isolated and characterized with X-ray crystallography, having the formula (PPh4)2MoO2(2,3-DHBA)2. Moreover, in aqueous solution, the reaction of ΜοΟ4 2- with 3,4-DHBA, in the presence or not of AscA, was studied with several spectroscopic methods, while complexes were isolated in two reaction steps. The antioxidant properties of the ligands 3,4-DHBA and AscA were also compared. In addition, a Mo(VI) complex with the ligand 2,3-DHP was prepared and characterized having the formula Μο2Ο4(2,3- DHP)4 .2H2O. Studying the reaction of Mo(VI) mainly with dihydroxybenzoic acids, in non-aqueous solutions, polymeric crystals were mainly isolated, suitable for X-ray determination. In particular, the crystals obtained were a tetrameric and a trimeric molybdenum complex with 2,3-DHBA and 2,5-DHBA with formulas (PPh4)2 .[Mo4O6(µ-O)4(µ3-OCH3)2(2,3-DHBA)2] and (PPh4)2 .[Mo3O6(µ-O)2(2,5-DHBA)2].CH3CN, Summary 186 respectively. The structure of the first complex consists of four distorted MoO6 octahedra with two cis- MoO2 2+ units and two molybdenum atoms having each ligand coordinated and one terminal oxygen atom while two triple bridged methanol molecules are present. The ligand 2,3-dihydroxybenzoic acid (2,3-DHBA) prefers the catecholate-type coordination with strong hydrogen bonding between the carboxylic hydrogen and the ortho-phenolic oxygen. The presence of coordinated methanol in the complex gives the opportunity of studying the catalytic activity of the complex in the oxidation of methanol to formaldehyde. The existence of the intermolecular hydrogen bond supports this probability. The structure of the second complex consists of three distorted MoO6 octahedra. The 2,5-dihydroxybenzoic acid (2,5-DHBA) acts as a tridentate ligand using both carboxyl oxygen atoms, giving thus an unusual trinuclear molybdenum complex with a unique coordination mode of the ligand. Interestingly, the 2,5-DHBA complex is the second that has been characterized by X-ray crystallography, since in the literature only a Zn2+ complex has been reported. L-carnitine and copper are involved in biological oxidations. In aqueous solution, a dimetallic complex was isolated with the formula [Cu2(L-carnitine)4(H2O)2].(ClO4)4 .H2O.CH2Cl2, which is the first L-carnitine metal complex characterized with X-ray crystallography. In this complex, four carnitine ligands are bridging the two copper atoms, through their carboxylate group. In ethanolic solution, another dimetallic complex was isolated with the formula [Cu2(L- carnitine)2Cl2(H2O)2].Cl, where the ligand is coordinated through one oxygen atom of the carboxyl group and the oxygen atom of the hydroxyl group. Finally, biological measurements were performed in some characterized complexes. Specifically, the antitumor activity (cell proliferation inhibitory activity) of the molybdenum complex with 2,5-DHBA, (PPh4)2 .[Mo3O6(µ-O)2(2,5-DHBA)2], to human leucemic cell lines was examined.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2007

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Litos, Charalambos
  • Λίτος, Χαράλαμπος

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/18533

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Litos, Charalambos; Λίτος, Χαράλαμπος. Μελέτη συµπλόκων των στοιχείων χαλκού, µολυβδαινίου και κοβαλτίου µε χηλικούς υποκαταστάτες. Εφαρµογή στη θεραπεία και τη διάγνωση. National and Kapodistrian University of Athens, 2007. http://hdl.handle.net/10442/hedi/18533